U
Remedent, Inc. REMI
$0.00 $0.0016.67% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Remedent, Inc. (OTC: REMI) has historically been associated with the dental products and cosmetic dentistry industry through the commercialization of aesthetic dental solutions, including veneer and restorative technologies. Public disclosures and historical market materials indicate that the company’s activities were connected to cosmetic dental applications and distribution relationships tied to international dental markets. Available public information suggests the company operated within the broader healthcare and dental device sector, though current operational scale and financial activity are difficult to verify from recent public disclosures.

Historically, the company was linked to the development and marketing of cosmetic dental products, including veneer systems marketed under the GlamSmile brand associated with the broader Remedent business network. Publicly available information indicates that the company pursued opportunities in aesthetic dentistry and dental restoration markets, targeting dental professionals and clinics seeking minimally invasive cosmetic procedures. However, recent operational updates, audited financial disclosures, and detailed investor communications appear limited. Data regarding current revenue drivers, active commercial operations, and market share is inconclusive based on available public sources.

Business Operations

Historical filings and market disclosures indicate that Remedent’s business activities centered on dental products, cosmetic restoration systems, and related healthcare distribution activities. The company’s commercial focus appeared to include dental veneers, whitening technologies, and aesthetic dental solutions marketed to dentists and dental clinics. Available information also suggests the company maintained relationships with international distributors and healthcare providers in select overseas markets.

Public records indicate that portions of the broader Remedent business had operational ties outside the United States, particularly in Europe and parts of Asia. Certain intellectual property, branding assets, and distribution arrangements were associated with cosmetic dental procedures and proprietary veneer systems. However, detailed information regarding current subsidiaries, active joint ventures, or ongoing operating segments could not be consistently verified across recent public filings and independent financial databases. Data concerning current assets, technology ownership, and active partnerships is inconclusive based on available public sources.

Strategic Position & Investments

Historically, Remedent positioned itself within the growing cosmetic dentistry and aesthetic healthcare market, emphasizing minimally invasive dental enhancement technologies and branded cosmetic solutions. Strategic efforts appeared focused on expanding adoption of aesthetic dentistry products through dental practitioner networks and international distribution relationships. Publicly available materials also indicate interest in expanding cosmetic dental branding into additional geographic markets.

There is limited verifiable evidence of significant recent acquisitions, large-scale capital investments, or active portfolio expansion initiatives tied directly to Remedent, Inc. Current information regarding emerging technology investments, material strategic transactions, or active subsidiary growth programs remains limited in publicly accessible filings. While historical references connect the company to the GlamSmile cosmetic dentistry platform, the present operational and strategic status of those activities cannot be fully verified through recent independent public disclosures.

Geographic Footprint

Remedent’s historical business presence extended beyond the United States through commercial relationships and distribution activities connected to cosmetic dentistry markets in Europe, Asia, and other international regions. Publicly available information associates parts of the broader Remedent organization with operations originating in Belgium, while Remedent, Inc. maintained a U.S. public market listing through the OTC market structure.

The company’s market exposure appears to have been concentrated in dental and cosmetic healthcare channels serving international dental practitioners and clinics. However, detailed and current information regarding active offices, operational facilities, employee footprint, or regional revenue concentration is limited in recent disclosures. Data concerning present-day international operational scale is inconclusive based on available public sources.

Leadership & Governance

Publicly available governance and executive information for Remedent, Inc. is limited and appears inconsistent across historical filings, OTC disclosures, and secondary financial databases. Historical records indicate leadership involvement from executives connected to the broader Remedent dental products organization, though recent confirmations of management structure are difficult to independently verify.

Available historical references include the following individuals associated with leadership or executive functions tied to Remedent-related operations:

  • Luc Martens – Founder and executive associated with the broader Remedent dental business
  • Geert Van Doorslaer – Executive leadership roles referenced in historical Remedent-related materials

Public disclosures suggest the company historically pursued a strategy centered on international cosmetic dentistry expansion, practitioner-focused distribution, and branded aesthetic dental technologies. However, current governance practices, board composition, and executive leadership status cannot be conclusively verified from recent public filings and independent market sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $223.96
B
AAPL NASDAQ $313.33
B
AVGO NASDAQ $427.76
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $111.85
Top Financial Stocks
See All »
B
B
JPM NYSE $357.52
B
V NYSE $362.50
Top Energy Stocks
See All »
B
ENB NYSE $51.28
B
ENB.TO TSX $71.55
Top Health Care Stocks
See All »
B
LLY NYSE $1,185.71
B
JNJ NYSE $259.24
B
ABBV NYSE $246.04
Top Real Estate Stocks
See All »
B
PLD NYSE $140.16
B
EQIX NASDAQ $1,042.62